Variability in cyclicity affects pain and other symptoms in female fibromyalgia syndrome patients

Journal of Musculoskeletal Pain

Volumn 6, Issue 4, 1998, Pages 5-22

  Anderberg, Ulla Maria ^a   Marteinsdottir, Ina ^a   Hallman, Jarmila ^a   Bäckström, Torbjörn ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Affective disorder; Cyclicity; Fibromyalgia syndrome; Pain; Sex steroids

Indexed keywords

SEX HORMONE;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBROMYALGIA; HUMAN; LUTEAL PHASE; MENSTRUAL CYCLE; OVULATION; PREMENSTRUAL SYNDROME; SYMPTOM;

EID: 0032440053     PISSN: 10582452     EISSN: None     Source Type: Journal    
DOI: 10.1300/J094v06n04_02     Document Type: Article

References (58)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fichtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russel IJ, Sheon RP: The American College of Rheumatology 1990 Criteria for the classification of Fibromyalgia. Arthritis Rheum 33:160-172, 1990.
2. Wolfe F, Ross K, Andersson J, Russel IJ, Hebert L: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19-28, 1995.
3. Waxman J, McSherry Zatkis S: Fibromyalgia and menopaus. Postgraduate Medicine 80(4):165-171, 1986.
4. Bäckström T, Baird DT, Bancroft J, Bixo M, Hammarbäck S, Sanders D, Smith S, Zetterlund B: Endocrinological aspects of cyclical mood changes during the menstrual cycle or the premenstrual syndrome. J Psychosom Obstet Gynaecol 2:8-20, 1983.
5. Halbreich U: Gonadal hormones and antihormones, serotonin and mood. Psychopharm Bull 26:291-295, 1990.
6. Guicheney P, Marcel D: Decrease of platelet serotonin content in ovariectomized female rats. Endocrinology 111(6):2412-2414, 1984.
7. Biegon A, Fischette CT, Rainbow TC, McEwen BS: Serotonin receptor modulation by estrogen in discrete brain nuclei. Neuroendocrinology 35:287-291, 1982.
8. Kendall D, Stancel GM, Enna SJ: Imipramine: Effect of ovarian steroids on modifications in serotonin receptor binding. Science 211:1183-1185, 1981.
9. Rehavi M, Sepcuti H, Weizman A: Upregulation by imipramin binding and serotonin uptake by estradiol in female rat brain. Brain Research 410:135-139, 1987.
10. Crowley WR, O'Donohue TL, Muth EA, Jacobowitz DM: Effects of ovarian hormones on levels of luteinizing hormone in plasma and on serotonin concentrations in discrete brain nuclei. Brain Research Bulletin 4:571-574, 1979.
11. Cone RI, Davis GA, Goy RW: Effects of ovarian steroids on serotonin metabolism within grossly dissected and microdissected brain regions of the ovariectomized rat. Brain Research Bulletin 7:639-644, 1981.
12. Rapkin AJ, Shoupe D, Reading A, Daneshgar KK, Goldman L, Bohn Y, Brann DW, Mahesh VB: Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone. J Soc Gynecol Invest 3(2): 93-98, 1996.
13. Shoupe D, Montz FJ, Lobo RA: The effects of estrogen and progestin on endogenous opioid activity in oophorectomized women. J Clin Endocrinol Metab. 60:178-183, 1985.
14. Wardlaw SL, Wehrenberg WB, Ferin M, Antunes JL, Frantz AG: Effect of sex steroids on B-endorphin in hypophyseal portal blood. J Clin Endocrinol Metab 55: 877-888, 1982.
15. Chrousos GP, Gold PW: The concepts of stress and stress system disorders. JAMA 267(9):1244-1252, 1992.
16. Vamkopoulus NC, Chrousos GP: Evidence of direct extrogenic of human corticotropin-releasing hormone gene expression: J Clin Invest 92 (4):1896-1902, 1993.
17. Young EA: The role of gonadal steroids in hypothalamic-pituitary-adrenal axis regulation. Critical Reviews in Neurobiol 9(4):371-381, 1995.
18. Russel IJ: Neurohormonal aspects of fibromyalgia syndrome. Rheum Dis Clin N Am 15:149-168, 1989.
19. Russel IJ, Vaeroy H, Javors M, Nyberg F: Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 35(5):550-556, 1992.
20. Russel IJ: Neurohormonal: Abnormal laboratory findings related to pain and fatigue in fibromyalgia. J Musculoske Pain 3(2):59-65, 1995.
21. Vaeroy H, Helle R, Forre O, et al: Elevated CSF levels of substance P and high incidence of Raynaud's phenomen in patients with fibromyalgia: new features for diagnosis. Pain 32:21-26, 1988.
22. Vaeroy H, Nyberg F, Terenius L: No evidence for endorphin deficiency following investigation of cerebrospinal fluid (CSF) dynorphin A and met-enkephalin-Arg6-Phe7. Pain 46(2):139-143, 1991.
23. Crofford LJ, Pillemer SR, Kalogeras KT, Cash JM, Michelson D, Kling MA, Sternberg EM, Gold PW, Chrousos GP, Wilder RL: Hypothalamic-pituitary-adrenal axis in patients with fibromyalgia. Arthritis Rheum 37:1583-1592, 1994.
24. Griep EN, Boersma JW, de Koet ER: Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheum 20(3):474, 1993.
25. Sundblad C, Wikander I, Andersch B, Eriksson E: A naturalistic study of Paroxetin in premenstrual syndrome: efficacy and side effects during ten cycles of treatment. In thesis: Serotonin, Androgens and Behaviour. Department of Pharmacology, University of Gothenburg, 1996.
26. Aloisi AM, Albonetti ME, Sacerdote P, Carli G: Sex dependent effects of stress and pain on choline acetyltransferase activity levels and B-endorphin content in discrete areas of the rat brain. The brain: source and target for sex steroid hormones. 1st Tuscania conference on reproductive medicine. Edited by AR Genazzani, F Petralgia, University of Pisa, Italy and RH Purdy, University of California, USA. The Pantheon Publishing Group, 1996, pp. 431-439.
27. Kavaliers M, Galea LAM: Sex differences in the expression of swim stress-induced analgesia in deer mice vary with the breading season. Pain 63:327-334, 1995.
28. Amundusson Å, Hermansson O, Blomqvist A: Estrogen receptor-like immumoreactivity in the medullary and spinal dorsal horn of the female rat. Neuroscience Letters 196:25-28, 1995.
29. Amundusson Å, Hermansson O, Blomqvist A: Colocalization oestrogen receptor immunoreactivity and preproenkephalin mRNA expression to neurons in the superficial laminae of the spinal and dorsal horn of rats. European Journal of Neuroscience 8:2440-2445, 1996.
30. Wolfe F, Ross K, Andeson J, Russel IJ: Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 21(1): 151-156, 1995.
31. Della Corte M, Procacci P, Bozza G, Buzzelli G: A study on the cutaneous pricking pain threshold in normal man. Arch Fisiol 64:141-170, 1965.
32. von Knorring L, Espvall M, Perris C: Averaged evoked responses, pain measures, and personality variables in patients with depressive disorders. Acta Psychiatr Scand Suppl 255:99-108, 1974.
33. von Knorring L: An experimental study of visual averaged evoked responses and pain measures in patients with depressive disorders. Biol Psychol 6(1):27-38, 1978.
34. Goolkasian P: Cyclic changes in pain perception: an ROC analysis. Perception and Psychophysics 27(6):499-504, 1980.
35. Herren RY: The effect of high and low female sex hormone concentration on the two-point threshold of pain and touch and upon tactile sensitivity. J Exp Psychol 16:324-327, 1933.
36. Veith JL, Anderson J, Slade SA, Thompson P, Laugel GR, Getzlaf S: Plasma B-endorphin, pain thresholds and anxiety levels across the human menstrual cycle. Physiology and Behavior 32:31-35, 1984.
37. The Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised. American Psychiatric Association. Washington, DC 20005, USA.
38. Hammarbäck S, Bäckström T, MacGibbon-Taylor B: Diagnosis of premenstrual tension syndrome: description and evaluation of a procedure for diagnosis and differential diagnosis. J Psychosom Obstet Gynaecol 10:25-42, 1989.
39. The Diagnostic and Statistical Manual of Mental Disorders, 4th edition. American Psychiatric Association. Washington, DC 20005, USA, 1994, pp. 715-718.
40. Spitzer R, Williams JBW, Gibbon M: Stuctural Clinical Interview for DSM-111-R-Patient Version (SCID-P, 6/1/81) 1997. Bioresearch.
41. Hallman J: The premenstrual syndrome-an equivalent of depression? Acta Psychiatr Scand 73:403-411, 1986.
42. Andersch B: Epidemiological, hormonal and water balance studies in premensstrual tension. Thesis. Department of Gynecology and Psychiatry, University of Gothenburg, Sweden, 1980.
43. von Knorring L: Depression. Nord Med 111:259-263, 1996.
44. Sartorius N: Depressive illness as a worldwide problem. In: Kielholz P ed.: Depression in every day pratice. Bern/Stuttgart/Vienna. Hans Huber Publ. 1974, pp. 18-24.
45. Ferin M, Van Vugt D, Wardlaw S: The hypothalamic control of the menstrual cycle and the role of endogenous opioid peptides. Recent Prog Horm Res 40: 441-445, 1984.
46. Vrbicky KW, Baumstark JS, Wells IC, Hilgers TW, Kable WT, Elias CJ: Evidence for the involvement of B-endorphin in the human menstrual cycle. Fertility and Sterility 38(6):701-704, 1982.
47. Wehrenberg WB, Wardlaw SL, Frantz AG, Ferin M: B-endorphin in hypophyseal portal blood: variations throughout the menstrual cycle. Endocrinology 3:879-881, 1982.
48. vonKnorring L, Perris C, Eisemann M, Eriksson U, Perris H: Pain as a symptom in depressive disorders. I. Relationship to a diagnostic subgroup and depressive symptomatology. Pain 15:19-26, 1983.
49. von Knorring L, Ekselius L: Idiopathic pain and depresion: Quality of life research 3:57-68, 1994.
50. Bäckströni T: Neuroendocrinology of premenstrual syndrome: Clin Obstet Gynaecol 35(3):612-628, 1992.
51. Sundström I, Ashbrook D, Bäckström T: Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study: Psychoneuroendocrinology 22(1): 25-38, 1997.
52. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR: Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 338(4):209-216, 1998.
53. Nörregard J, Volkmann H, Danneskiold-Samoe B: A randomized controlled trial of Citalopram in the treatment of fibromyalgia. Pain 61:445-449, 1995.
54. Eriksson E, Hedberg MA, Andersch B, Sundblad C: The serotonin reuptake inhibitor Paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 12(2):167-176, 1995.
55. Ashby CR, Carr LA, Cook CL, Steptoe MM, Franks DD: Alteration of 5-HT uptake by plasma fractions in the premenstrual syndrome. J Neural Transm (Gen-Sect) 79:41-50, 1990.
56. Blum I, Nessiel L, David A, Graff E, Harsat A, Weissglas L, Gabbay U, Sulke SJ, Yerushalmy Y, Vered Y: Plasma neurotransmitter profile during different phases of the ovulatory cycle. J Clin Endocrinol Metabol 75:924-929, 1992.
57. Crofford LJ: The Hypothalamic-Pituitary-Adrenal Stress Axis in the Fibromyalgia syndrome. J Musculoske Pain 4(1/2):181-200, 1996.
58. Genazzani AR, Lemarchand-Beraud T, Aubert ML, Felber JP: Pattern of plasma ACTH, hGH, and cortisol during the menstrual cycle. Endocrinol Metabol 41(3): 431-437, 1975.